Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
复制标题
LASS2 和 TGF-β1 的共表达预测肝细胞癌的不良预后
DOI:
10.1038/srep32421
复制
发表时间:
2016-09-01
影响因子:
4.6
通讯作者:
Jin H
中科院分区:
文献类型:
--
作者:
Ruan H;Wang T;Yang C;Jin G;Gu D;Deng X;Wang C;Qin W;Jin H
Longevity assurance homolog 2 of yeast LAG1 (LASS2) has been reported to act as an important tumor suppressor in the development of human cancers. However, little is known about the prognostic value of LASS2 in hepatocellular carcinoma (HCC) . In the present study, we analyzed correlation between LASS2 and TGF-β1 levels, and evaluated their prognostic values in HCC patients. We first analyzed the expression of LASS2 and TGF-β1 in two independent cohorts (test cohort: 184 HCC patients; validation cohort: 118 HCC patients) using immunohistochemistry (IHC). Kaplan-Meier survival and Cox regression analyses were executed to evaluate the prognosis of HCC. The results of IHC analysis revealed a positive correlation between the expression of LASS2 and TGF-β1. HCC Patients with low expression of LASS2 and TGF-β1 had shorter overall survival (OS) and time to recurrence (TTR) than patients with high expression of LASS2 and TGF-β1. Furthermore, combination of LASS2 and TGF-β1 was an independent and significant risk factor for OS and TTR. In conclusion, low expression of LASS2 and TGF-β1 contributes to the aggressiveness and poor prognosis of HCC, and may represent a novel prognostic biomarker for HCC patients.
登录
查看更多内容
影响因子:
13.5
作者:
Senturk, Serif;Mumcuoglu, Mine;Ozturk, Mehmet
通讯作者:
Ozturk, Mehmet
影响因子:
8
作者:
Fan, S.;Niu, Y.;Qin, W.
通讯作者:
Qin, W.
影响因子:
3.9
作者:
Ke, Rong-Hu;Wang, Yin;Xiong, Ji
通讯作者:
Xiong, Ji
影响因子:
--
作者:
Dwivedi SK;McMeekin SD;Slaughter K;Bhattacharya R
通讯作者:
Bhattacharya R
影响因子:
11.2
作者:
Forrester, E;Chytil, A;Moses, HL
通讯作者:
Moses, HL